Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: What is the role for nonpharmacological prophylaxis?

Désirée Caselli, Simone Cesaro, Susanna Livadiotti, Ottavio Ziino, Olivia Paolicchi, Giulio Zanazzo, Giuseppe M. Milano, Maria Licciardello, Angelica Barone, Monica Cellini, De Santis Raffaella, Mareva Giacchino, Mario Renato Rossi, Maurizio Aricò, Elio Castagnola

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The most intensive chemotherapy regimens were used in the past for leukemia patients who were the main focus of trials on infections; today there are increasing numbers of children with solid cancer and considerable risk of infection who do receive intensive stand ard-dose chemotherapy. Despite a continuous will to protect the immune-compromised child from infections, evidence-based indications for intervention by non-pharmacological tools is still lacking in the pediatric hematology-oncology literature. Guidelines on standard precautions as well as precautions to avoid transmission of specific infectious agents are available. As a result of a consensus discussion, the Italian Association for Pediatric Hematology-Oncology (AIEOP) Cooperative Group centers agree that for children treated with chemotherapy both of these approaches should be implemented and vigorously enforced, while additional policies, including strict environmental isolation, should be restricted to patients with selected clinical conditions or complications. We present here a study by the working group on infectious diseases of AIEOP.

Original languageEnglish
Article numbere9
JournalPediatric Reports
Volume3
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Hematology
Pediatrics
Drug Therapy
Infection
Communicable Diseases
Leukemia
Guidelines
Neoplasms

Keywords

  • Chemotherapy
  • Infections
  • Leukemia
  • Pediatrics

ASJC Scopus subject areas

  • Pediatrics

Cite this

Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting : What is the role for nonpharmacological prophylaxis? / Caselli, Désirée; Cesaro, Simone; Livadiotti, Susanna; Ziino, Ottavio; Paolicchi, Olivia; Zanazzo, Giulio; Milano, Giuseppe M.; Licciardello, Maria; Barone, Angelica; Cellini, Monica; Raffaella, De Santis; Giacchino, Mareva; Rossi, Mario Renato; Aricò, Maurizio; Castagnola, Elio.

In: Pediatric Reports, Vol. 3, No. 1, e9, 2011.

Research output: Contribution to journalArticle

Caselli, Désirée ; Cesaro, Simone ; Livadiotti, Susanna ; Ziino, Ottavio ; Paolicchi, Olivia ; Zanazzo, Giulio ; Milano, Giuseppe M. ; Licciardello, Maria ; Barone, Angelica ; Cellini, Monica ; Raffaella, De Santis ; Giacchino, Mareva ; Rossi, Mario Renato ; Aricò, Maurizio ; Castagnola, Elio. / Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting : What is the role for nonpharmacological prophylaxis?. In: Pediatric Reports. 2011 ; Vol. 3, No. 1.
@article{dce8af590a3a4744b7f5bdeb56c19387,
title = "Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: What is the role for nonpharmacological prophylaxis?",
abstract = "The most intensive chemotherapy regimens were used in the past for leukemia patients who were the main focus of trials on infections; today there are increasing numbers of children with solid cancer and considerable risk of infection who do receive intensive stand ard-dose chemotherapy. Despite a continuous will to protect the immune-compromised child from infections, evidence-based indications for intervention by non-pharmacological tools is still lacking in the pediatric hematology-oncology literature. Guidelines on standard precautions as well as precautions to avoid transmission of specific infectious agents are available. As a result of a consensus discussion, the Italian Association for Pediatric Hematology-Oncology (AIEOP) Cooperative Group centers agree that for children treated with chemotherapy both of these approaches should be implemented and vigorously enforced, while additional policies, including strict environmental isolation, should be restricted to patients with selected clinical conditions or complications. We present here a study by the working group on infectious diseases of AIEOP.",
keywords = "Chemotherapy, Infections, Leukemia, Pediatrics",
author = "D{\'e}sir{\'e}e Caselli and Simone Cesaro and Susanna Livadiotti and Ottavio Ziino and Olivia Paolicchi and Giulio Zanazzo and Milano, {Giuseppe M.} and Maria Licciardello and Angelica Barone and Monica Cellini and Raffaella, {De Santis} and Mareva Giacchino and Rossi, {Mario Renato} and Maurizio Aric{\`o} and Elio Castagnola",
year = "2011",
doi = "10.4081/pr.2011.e9",
language = "English",
volume = "3",
journal = "Pediatric Reports",
issn = "2036-749X",
publisher = "PagePress",
number = "1",

}

TY - JOUR

T1 - Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting

T2 - What is the role for nonpharmacological prophylaxis?

AU - Caselli, Désirée

AU - Cesaro, Simone

AU - Livadiotti, Susanna

AU - Ziino, Ottavio

AU - Paolicchi, Olivia

AU - Zanazzo, Giulio

AU - Milano, Giuseppe M.

AU - Licciardello, Maria

AU - Barone, Angelica

AU - Cellini, Monica

AU - Raffaella, De Santis

AU - Giacchino, Mareva

AU - Rossi, Mario Renato

AU - Aricò, Maurizio

AU - Castagnola, Elio

PY - 2011

Y1 - 2011

N2 - The most intensive chemotherapy regimens were used in the past for leukemia patients who were the main focus of trials on infections; today there are increasing numbers of children with solid cancer and considerable risk of infection who do receive intensive stand ard-dose chemotherapy. Despite a continuous will to protect the immune-compromised child from infections, evidence-based indications for intervention by non-pharmacological tools is still lacking in the pediatric hematology-oncology literature. Guidelines on standard precautions as well as precautions to avoid transmission of specific infectious agents are available. As a result of a consensus discussion, the Italian Association for Pediatric Hematology-Oncology (AIEOP) Cooperative Group centers agree that for children treated with chemotherapy both of these approaches should be implemented and vigorously enforced, while additional policies, including strict environmental isolation, should be restricted to patients with selected clinical conditions or complications. We present here a study by the working group on infectious diseases of AIEOP.

AB - The most intensive chemotherapy regimens were used in the past for leukemia patients who were the main focus of trials on infections; today there are increasing numbers of children with solid cancer and considerable risk of infection who do receive intensive stand ard-dose chemotherapy. Despite a continuous will to protect the immune-compromised child from infections, evidence-based indications for intervention by non-pharmacological tools is still lacking in the pediatric hematology-oncology literature. Guidelines on standard precautions as well as precautions to avoid transmission of specific infectious agents are available. As a result of a consensus discussion, the Italian Association for Pediatric Hematology-Oncology (AIEOP) Cooperative Group centers agree that for children treated with chemotherapy both of these approaches should be implemented and vigorously enforced, while additional policies, including strict environmental isolation, should be restricted to patients with selected clinical conditions or complications. We present here a study by the working group on infectious diseases of AIEOP.

KW - Chemotherapy

KW - Infections

KW - Leukemia

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=83655182374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655182374&partnerID=8YFLogxK

U2 - 10.4081/pr.2011.e9

DO - 10.4081/pr.2011.e9

M3 - Article

C2 - 21647282

AN - SCOPUS:83655182374

VL - 3

JO - Pediatric Reports

JF - Pediatric Reports

SN - 2036-749X

IS - 1

M1 - e9

ER -